Products
brain health
cell health
joint health
immune health
digestive health
other products
how to order

Learn@MEND
newsletter
MEND QSA
MENDWARE
MEND braininfo
vital resources

Efficacy with SSRI (selective serotonin re-uptake inhibitors)

Review of Clinical Efficacy:

1. Full control of panic disorder (Go to Clinical ACTIONS:)
2. Partial control of panic disorder (Go to Clinical ACTIONS:)
3. No control of panic disorder (Go to Clinical ACTIONS:)

Full Control of Panic Disorder

1. Complete initial therapeutic phase (10 to 12 weeks)
2. Complete maintenance phase (12 weeks)
3. Complete relapse prevention phase (12 weeks)
4. Needs Assessment:
   1. Risks of discontinuation of medication and therapy
   2. Continued treatment with medication and application of cognitive behavioral skills

Partial Control of Panic Disorder

1. Assess compliance with medication and therapy
2. Continue present dose and intensify cognitive and behavioral therapy
3. Adjust dose if no side-effects or side-effects are tolerable
4. Consider augmentation and other medications (Go to Medication OPTIONS:)

No Control of Panic Disorder

1. Assess compliance with medication and therapy
2. Continue present dose and intensify cognitive and behavioral therapy
3. Adjust dose if no side-effects or side-effects are tolerable
4. Consider augmentation and other medications (Go to Medication OPTIONS:)

Partial or No Control of Panic Disorder

1. Augmentation:
   1. Buspirone
   2. HPB
   3. Beta blocker
2. Medication Change
   1. TCA (tricyclic antidepressant)
   2. HPB (high potency benzodiazepine)
   3. MAOI (monamine oxidase inhibitor)